Candida Prosthetic Joint Infection. A Review of Treatment Methods.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28540147)

Published in J Bone Jt Infect on February 05, 2017

Authors

Fernando Cobo1, Javier Rodríguez-Granger1, Antonio Sampedro1, Luis Aliaga-Martínez2, José María Navarro-Marí1

Author Affiliations

1: Department of Microbiology, Hospital Virgen de las Nieves, Granada, Spain.
2: Department of Internal Medicine, Hospital Virgen de las Nieves, Granada, Spain.

Articles cited by this

Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19

Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev (2000) 9.83

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52

Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J (2013) 2.72

Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop (2012) 2.05

The Chitranjan Ranawat Award: Long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res (2006) 2.02

Prosthetic joint infection. Clin Microbiol Rev (2014) 1.97

Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: differential diagnosis between infectious and non-infectious loosening. Clin Orthop Relat Res (1981) 1.89

Total hip arthroplasties: what are the reasons for revision? Int Orthop (2007) 1.55

Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg (2001) 1.48

Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am (2009) 1.38

Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol (2009) 1.37

Elution and mechanical properties of antifungal bone cement. J Arthroplasty (2007) 1.29

Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis (2002) 1.26

Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol (2011) 1.17

Candida arthritis after total knee arthroplasty--a case of successful treatment without prosthesis removal. Acta Orthop Scand (1997) 1.07

Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol (2010) 1.06

Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplasty (2011) 0.99

Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer. Knee Surg Sports Traumatol Arthrosc (2010) 0.98

Candida glabrata infection after total hip arthroplasty. J Infect (2001) 0.98

What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res (2013) 0.97

2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop (2013) 0.93

Fungal infection of prosthetic joints: a report of two cases. J Rheumatol (1983) 0.93

Candidal prosthetic hip infection in a patient with previous candidal septic arthritis. J Arthroplasty (2004) 0.92

Periprosthetic candidal infections following arthroplasty. Rev Infect Dis (1989) 0.91

Candida infection after total knee arthroplasty. Management without resection or amphotericin B. J Arthroplasty (1997) 0.91

Candida glabrata periprosthetic infection: a case report and literature review. J Arthroplasty (2004) 0.90

Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect (2001) 0.90

Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty (1998) 0.90

Candida albicans infection of prosthetic joints. Orthopedics (1996) 0.89

Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report. J Bone Joint Surg Am (1984) 0.88

Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. J Arthroplasty (1997) 0.88

Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br (2012) 0.88

Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty (2001) 0.88

Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis (1988) 0.88

Prosthetic knee Candida parapsilosis infection. J Arthroplasty (1998) 0.88

Candida infection after implant arthroplasty. A case report. J Bone Joint Surg Am (1986) 0.88

Infection of a total knee arthroplasty by Candida parapsilosis. A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg (1996) 0.87

Fluconazole-impregnated beads in the management of fungal infection of prosthetic joints. J Bone Joint Surg Br (2001) 0.86

Candida albicans infection of a prosthetic knee replacement: a case report. Med J Malaysia (2000) 0.86

Candida infection in total knee arthroplasty with successful reimplantation. J Knee Surg (2010) 0.86

Candida infection of a prosthetic shoulder joint. Skeletal Radiol (1983) 0.85

Infection with Candida albicans of a total knee arthroplasty. Case report and review of the literature. Clin Orthop Relat Res (1988) 0.85

Fungal infection of a total knee prosthesis: successful treatment using articulating cement spacers and staged reimplantation. Orthopedics (2002) 0.85

Pathogenesis of Candida albicans biofilm. Pathog Dis (2016) 0.84

Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole. Arch Oral Biol (2011) 0.84

An extremely uncommon infection: Candida glabrata arthritis after total knee arthroplasty. Scand J Infect Dis (2002) 0.83

Candida parapsilosis prosthetic joint infection unresponsive to treatment with fluconazole. Clin Infect Dis (1995) 0.83

Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med (1993) 0.82

Results of combined amphotericin B-5-fluorcytosine therapy for prosthetic knee joint infected with Candida parapsilosis. J Rheumatol (1980) 0.82

Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis (2010) 0.81

Fungal prosthetic joint infection after total knee arthroplasty. Indian J Orthop (2013) 0.81

Prosthetic joint infection due to Candida parapsilosis in the UK: case report and literature review. Eur J Clin Microbiol Infect Dis (1992) 0.81

Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents (2008) 0.81

Pseudotumor of the Hip due to Fungal Prosthetic Joint Infection. Case Rep Orthop (2013) 0.80

Staged reimplantation of a total hip prosthesis after infection with Candida albicans. A report of two cases. J Bone Joint Surg Am (1990) 0.80

Successful 1-stage exchange total knee arthroplasty for fungal infection. J Arthroplasty (1998) 0.80

Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans. Ann Pharmacother (2009) 0.79

Candida albicans infection of a prosthetic knee replacement: a report and review of the literature. J Rheumatol (1988) 0.79

Candida glabrata prosthesis infection following pyelonephritis and septicaemia. Scand J Infect Dis (1997) 0.79

Infection of a total knee prosthesis by Candida glabrata: a case report. Acta Orthop Belg (2005) 0.78

Caspofungin as treatment for Candida glabrata hip infection. Int J Antimicrob Agents (2005) 0.78

Candida albicans infection of a prosthetic knee replacement. J Rheumatol (1988) 0.78

[In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Rev Iberoam Micol (2007) 0.78

Single-stage revision for fungal peri-prosthetic joint infection: a single-centre experience. Bone Joint J (2014) 0.77

Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report. Infect Dis (Lond) (2016) 0.76

Candida tropicalis: diagnostic dilemmas for an unusual prosthetic hip infection. J R Army Med Corps (2013) 0.76

May one-stage exchange for Candida albicans peri-prosthetic infection be successful? Orthop Traumatol Surg Res (2015) 0.76

Candida glabrata prosthetic hip infection. Am J Orthop (Belle Mead NJ) (2012) 0.75

Candida glabrata infection following total hip arthroplasty: A case report. Exp Ther Med (2013) 0.75